CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
Seungah Lee, Dong Yun Lee
Ann Pediatr Endocrinol Metab. 2017;22(1):15-26.   Published online March 31, 2017
DOI: https://doi.org/10.6065/apem.2017.22.1.15

Excel Download

Glucagon-like peptide-1 receptor agonists
Baptist Gallwitz
Handbook of Incretin-based Therapies in Type 2 Diabetes. 2016;31-43   Crossref logo
Link1
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
Hyun Jin Kim
The Journal of Korean Diabetes. 2018;19(1):35   Crossref logo
Link1 Link2 Link3
Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
Gagik R. Galstyan, Evgeniya A. Karataeva, Ekaterina A. Yudovich
Diabetes mellitus. 2017;20(4):286-298   Crossref logo
Link1 Link2
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
Seungah Lee, Dong Yun Lee
Annals of Pediatric Endocrinology & Metabolism. 2017;22(1):15   Crossref logo
Link1 Link2 Link3
Glucagon-like peptide-1 receptor agonists and their effects on weight reduction
Shyi-Jang Shin
Journal of Diabetes Investigation. 2012;3(6):490-491   Crossref logo
Link1
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
K. B. Hansen, F. K. Knop, J. J. Holst, T. Vilsbøll
International Journal of Clinical Practice. 2009;63(8):1154-1160   Crossref logo
Link1
Emerging New Therapies for the Treatment of Type 2 Diabetes Mellitus: Glucagon-like Peptide-1 Receptor Agonists
Christopher A. Lindamood, James R. Taylor
Clinical Therapeutics. 2015;37(3):483-493   Crossref logo
Link1 Link2
The role of glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
Erin St Onge, Shannon Miller, Elizabeth Clements, Lindsay Celauro, Ke’la Barnes
Journal of Translational Internal Medicine. 2017;5(2):79-89   Crossref logo
Link1 Link2
Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
Young Min Cho, Rhonda D. Wideman, Timothy J. Kieffer
Endocrinology and Metabolism. 2013;28(4):262   Crossref logo
Link1 Link2 Link3
Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists
Qiuhe Ji
Clinical Therapeutics. 2017;39(6):1244-1264   Crossref logo
Link1 Link2